Explicit|17|39|243..246|1,2|but|||but|||Comparison.Concession.Contra-expectation||||Wr|Comm|Null|Null||||175..241|1,0|Bristol-Myers Co. and Squibb Corp., Princeton, N.J., merged Oct. 4|Inh|Null|Null|Null||||247..312|1,3|the new company reported third-period earnings for both companies|Inh|Null|Null|Null|||||||||
Implicit|17|39||||314|2||by contrast||Comparison.Contrast.Opposition||||Wr|Comm|Null|Null||||243..312|1,2;1,3;1,4|but the new company reported third-period earnings for both companies|Inh|Null|Null|Null||||314..390|2|For the fourth quarter, Bristol-Myers Squibb will report one set of earnings|Inh|Null|Null|Null|||||||||
Implicit|17|39||||531|4||while||Expansion.Conjunction||||Wr|Comm|Null|Null||||394..529|3|Bristol-Myers said net income rose 15% to $266.2 million, or 93 cents a share, from $232.3 million, or 81 cents a share, a year earlier|Inh|Null|Null|Null||||531..582|4|Sales gained 5% to $1.59 billion from $1.52 billion|Inh|Null|Null|Null|||||||||
Implicit|17|39||||691|6||while||Expansion.Conjunction||||Wr|Comm|Null|Null||||586..689|5|Squibb Corp. said net rose 17% to $144.5 million, or $1.47 a share, from $123 million, or $1.25 a share|Inh|Null|Null|Null||||691..743|6|Sales were $730.1 million, up 7% from $679.5 million|Inh|Null|Null|Null|||||||||
